Cleerly CONFIRM2 study finds women with CAD at higher risk of MACE

Retrieved on: 2025-04-01 15:43:06

Tags for this article:

Vascular diseases

Aging-associated diseases

Atheroma

Quantitative computed tomography

Atherosclerosis

Peripheral artery disease

Angina

Cardiovascular disease

Coronary artery disease

Coronary arteries

Click the tags to see associated articles and topics

Cleerly CONFIRM2 study finds women with CAD at higher risk of MACE. View article details on hiswai:

Summary

The article discusses Cleerly's CONFIRM2 trial using AI-based Quantitative Computed Tomography (AI-QCT) for predicting cardiovascular risks, highlighting gender disparities in coronary artery disease. The key concept of 'Business intelligence' relates to leveraging AI-QCT insights. Tags align with vascular diseases and related conditions.

Article found on: www.clinicaltrialsarena.com

View Original Article